Lung Cancer
Conference Coverage
Reducing risk for thrombosis in patients with lung cancer
This risk may be increased by certain cancer drugs, which seems to be the case for the combination of innovative targeted therapies lazertinib-...
Latest News
Few of those eligible get lung cancer screening, despite USPSTF recommendations
Fewer than 13% who are eligible get CT screening. Results highlight the need for education, Medicare coverage, and recognition of stigma’s role,...
From the Journals
Electronic nose may sniff out early lung cancer in COPD
Molecular profiling of exhaled breath using electronic nose (eNose) technology has shown potential as a method of early detection by identifying...
Conference Coverage
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology
A pair of new studies show that drugs can reduce cancer risk when cells are elusive.
From the Journals
Safe to stop immunotherapy at 2 years in stable lung cancer
“These data may provide reassurance to us and patients that discontinuing treatment at 2 years can confer the same overall survival as extended...
Conference Coverage
SCLC: Bispecific antibody shows phase 1 promise
The antibody targets delta-like ligand 3, which is one of few surface markers for small cell lung cancer.
From the Journals
Warning on use of sotorasib after ICI in lung cancer
“We suggest avoiding starting sotorasib within 30 days from the last anti–PD-(L)1 infusion.”
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
Feature
The breathtaking effects of climate change
“What we’re going to see is not just new diseases but also exacerbation of chronic diseases.”
Latest News
Asthma tied to increased risk for multiple cancers
Treatment with an inhaled steroid may lower that risk, perhaps by keeping inflammation in check.